img
img
Turkish Real Life Atrial Fibrillation in Clinical Practice: TRAFFIC Study       
Yazarlar (51)
Can Yücel Karabay
Türkiye
Dr. Öğr. Üyesi Muammer KARAKAYALI Dr. Öğr. Üyesi Muammer KARAKAYALI
Kafkas Üniversitesi, Türkiye
Ayşegül Ülgen Kunak
Türkiye
Murat Çap
Türkiye
Mehmet Ali Astarcıoğlu
Türkiye
Taner Şen
Türkiye
Mehmet Kaplan
Türkiye
Muharrem Said Coşgun
Türkiye
Fahriye Vatansever Ağca
Türkiye
Uğur Arslan
Türkiye
Gönül Açıksarı
Türkiye
Er Fahri
Kadir Uğur Mert
Türkiye
Öner Özdoğan
Türkiye
Serhat Çalışkan
Türkiye
Ercan Akşit
Türkiye
Ahmet Seyda Yılmaz
Türkiye
Emrah Aksakal
Türkiye
Zeki Şimşek
Türkiye
Süleyman Çağan Efe
Türkiye
Gülşah Aktüre
Türkiye
Ferit Böyük
Türkiye
Özcan Başaran
Türkiye
Mehmet Ballı
Türkiye
Ahmet Oğuz Aslan
Gamze Babur Güler
Türkiye
Ulaankhuu Batgerel
Türkiye
Flora Özkalaycı Kaçar
Türkiye
Bedri Caner Kaya
Türkiye
Batur Gönenç Kanar
Türkiye
Dr. Öğr. Üyesi Muammer KARAKAYALI Dr. Öğr. Üyesi Muammer KARAKAYALI
Türkiye
Emrah Erdoğan
Türkiye
Gürkan İş
Türkiye
Sedat Kalkan
Türkiye
Demirel Sinan
Uğur Aksu
Türkiye
Ümit Güray
Türkiye
Hasan Aydın Baş
Türkiye
Murat Gök
Türkiye
Mehmet Yılmaz
Türkiye
Barış Şimşek
Türkiye
Zeynep Kolak
Öz Melih
Utku Uluköksal
Hüseyin Emre Kuloğlu
Türkiye
Gizem Çabuk
Fatma Köksal
Türkiye
Ahmet Cem Nizam
Türkiye
Rabia Çoldur
Türkiye
Faysal Şaylık
Türkiye
İbrahim Halil Tanboğa
Türkiye
Devamını Göster
Özet
Background: Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia worldwide and is associated with an increased risk of thromboembolism, ischemic stroke, impaired quality of life, and mortality. The latest research that shows the prevalence and incidence of AF patients in Türkiye was the Turkish Adults’ Heart Disease and Risk Factors study, which included 3,450 patients and collected data until 2006/07.The Turkish Real Life Atrial Fibrillation in Clinical Practice (TRAFFIC) study is planned to present current prevalence data, reveal the reflection of new treatment and risk approaches in our country, and develop new prediction models in terms of outcomes. Methods: The TRAFFIC study is a national, prospective, multicenter, observational registry. The study aims to collect data from at least 1900 patients diagnosed with atrial fibrillation, with the participation of 40 centers from Türkiye. The following data will be collected from patients: baseline demographic characteristics, medical history, vital signs, symptoms of AF, ECG and echocardiographic findings, CHADS2-VASC2 and HAS-BLED (1-year risk of major bleeding) risk scores, interventional treatments, antithrombotic and antiarrhythmic medications, or other medications used by the patients. For patients who use warfarin, international normalized ratio levels will be monitored. Follow-up data will be collected at 6, 12, 18, and 24 months. Primary endpoints are defined as systemic embolism or major safety endpoints (major bleeding, clinically relevant nonmajor bleeding, and minor bleeding as defined by the International Society on Thrombosis and Hemostasis). The main secondary endpoints include major adverse cardiovascular events (systemic embolism, myocardial infarction, and cardiovascular death), all-cause mortality, and hospitalizations due to all causes or specific reasons. Results: The results of the 12-month follow-up of the study are planned to be shared by the end of 2023. Conclusion: The TRAFFIC study will reveal the prevalence and incidence, demographic characteristics, and risk profiles of AF patients in Türkiye. Additionally, it will provide insights into how current treatments are reflected in this population. Furthermore, risk prediction modeling and risk scoring can be conducted for patients with AF.
Anahtar Kelimeler
Arrhythmias | atrial fibrillation | atrial fibrillation/flutter | bleeding | catheter ablation
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayımlanan tam makale
Dergi Adı The Anatolian Journal of Cardiology
Dergi ISSN 2149-2263 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q3
Makale Dili İngilizce
Basım Tarihi 01-2024
Cilt No 28
Sayı 2
Sayfalar 87 / 93
Doi Numarası 10.14744/AnatolJCardiol.2023.3616
Makale Linki http://dx.doi.org/10.14744/anatoljcardiol.2023.3616